Riskpilot← Back to searchSign inGet full accessAuxesis Medtech AB
ABActiveOrg 5594811860Storsjöstråket 15Manufacture of pharmaceutical preparations · NACE 2120Est. 20240 employees
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
62.4%
Financial strength
Net profit 2024
SEK -102K
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -102K | — |
| Net profit | SEK -102K | — |
| Total assets | SEK 85K | — |
| Equity | SEK 53K | — |
| Employees | 0 | — |
Legal name
Auxesis Medtech AB
Org number
5594811860
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
24 april 2024
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska framställa, producera och försälja medicinska preparat för människor, djur och därmed förenlig verksamhet.
Address
Storsjöstråket 15
Email
roar.adelsten@auxesispharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2024 |
|---|---|
| Revenue | 0 |
| Staff expenses | — |
| EBITDA | −102 |
| Depreciation & amort. | −0 |
| EBIT | −102 |
| Net financials | — |
| Profit before tax | −102 |
| Tax | −0 |
| Net profit | −102 |
| Item | 2024 |
|---|---|
| Total assets | 85 |
| Equity | 53 |
| Long-term debt | 0 |
| Short-term debt | 32 |
| Total debt | 32 |
EBITDA margin
-10200000.0%
This company
15.8%
Market median
-64557062% vs market
20242024
Equity ratio
62.4%
This company
38.2%
Market median
+63% vs market
20242024
Return on equity
-192.5%
This company
18.4%
Market median
-1146% vs market
20242024
Net profit margin
-10200000.0%
This company
8.1%
Market median
-125926026% vs market
20242024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20242024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20242024
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
OR Chief Auditor | Chief Auditor | 2024 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Deputy Board Member | 2024 – 2024 | |
| Board of Directors | 2024 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
AUXESIS PHARMA HOLDING AB (publ)
Auxesis Medtech AB Board members of Auxesis Medtech AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Olov Rickard Tony Sjölund | Chief Auditor | 0 companies |
| Eva Margareta Eljans | Deputy Board Member | 0 companies |
| Lars Erik Larsson | Deputy Board Member | 0 companies |
| Roar Adelsten | Board of Directors | 0 companies |
| Anita Helena Berggren | Board of Directors | 0 companies |